Produced in BALB/c mouse ascites after inoculation with hybridoma of mouse myeloma cells (NS-1) and spleen cells derived from a BALB/c mouse immunized with Baculovirusexpressed recombinant human GRα (2-60 aa).
BALB/c mouse ascites inoculated with hybridoma of spleen cells of BALB/c mouse immunized with recombinant human GRα (2-60 aa) and mouse myelomacells (NS-1)
Produced in BALB/c mouse ascites after inoculation with hybridoma of mouse myelomacells (NS-1) and spleen cells derived from a BALB/c mouse immunized with Baculovirusexpressed recombinant human COUP-TF I (6-81 aa)
BALB/c mouse ascites inoculated with hybridoma of spleen cells of BALB/c mouse immunized with recombinant human COUP-TF I (6-81 aa) and mouse myelomacells (NS-1)
Produced in BALB/c mouse ascites after inoculation with hybridoma of mouse myeloma cells (NS-1) and spleen cells derived from a BALB/c mouse immunized with E.coli-expressed recombinant human EAR2 (2-50 aa).
BALB/c mouse ascites inoculated with hybridoma of spleen cells of BALB/c mouse immunized with recombinant human PPARγ2 (2-28 aa) and mouse myelomacells (NS-1)
BALB/c mouse ascites inoculated with hybridoma of spleen cells of BALB/c mouse immunized with recombinant human RXRα (2-133 aa) and mouse myelomacells (NS-1)
BALB/c mouse ascites inoculated with hybridoma of spleen cells of BALB/c mouse immunized with recombinant human LXRα (2-97 aa) and mouse myelomacells (NS-1)
BALB/c mouse ascites inoculated with hybridoma of spleen cells of BALB/c mouse immunized with recombinant human PPARγ2 (2-136 aa) and mouse myelomacells (NS-1)
BALB/c mouse ascites inoculated with hybridoma of spleen cells of BALB/c mouse immunized with recombinant human LRH-1 (2-33 aa) and mouse myelomacells (NS-1)
BALB/c mouse ascites inoculated with hybridoma of spleen cells of BALB/c mouse immunized with recombinant human LXRβ (2-86 aa) and mouse myelomacells (NS-1)
BALB/c mouse ascites inoculated with hybridoma of spleen cells of BALB/c mouse immunized with recombinant human HNF4α (3-49 aa) and mouse myelomacells (NS-1)
BALB/c mouse ascites inoculated with hybridoma of spleen cells of BALB/c mouse immunized with recombinant human PPARδ (1-60 aa) and mouse myelomacells (NS-1)
BALB/c mouse ascites inoculated with hybridoma of spleen cells of BALB/c mouse immunized with recombinant human EZFIT (6-199 aa) and mouse myelomacells (NS-1)
BALB/c mouse ascites inoculated with hybridoma of spleen cells of BALB/c mouse immunized with recombinant human SALL1 (258-499 aa) and mouse myelomacells (NS-1)
Produced in BALB/c mouse ascites inoculated with hybridoma of mouse myelomacells (NS-1) and spleen cells of a BALB/c mouse, which immunized with recombinant human EAR2 (13-44aa) produced by Baculovirus
Produced in BALB/c mouse ascites after inoculation with hybridoma of mouse myeloma cells (NS-1) and spleen cells derived from a BALB/c mouse immunized with Baculovirus-expressed recombinant human HNF4γ (96-408 aa)